The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1266
July 30, 2007
View Complete Issue         Table of Contents 2019 
Drugs for Community-Acquired Bacterial Pneumonia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Community-Acquired Bacterial Pneumonia
July 30, 2007 (Issue: 1266)
Most patients with community-acquired pneumonia (CAP) are treated empirically. New guidelines published jointly by the Infectious Diseases Society of America and the American Thoracic Society have recently become available.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Community-Acquired Bacterial Pneumonia
Article code: 1266b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.